salariuspharma.com (SLRX) Company Gross Revenue

Corporate emblem and logo of Salarius Pharmaceuticals, Inc. (SLRX)

Salarius Pharmaceuticals (SLRX) operational sales demonstrate the impact of developing unique biologics protected by patents against price wars. However, volatility is driven by reliance on external manufacturing and the outcomes of drug trials. The sector's neutral geopolitical status provides stability. The value of 0.00 serves as the current indicator of this trend, allowing for the real-time tracking of the actual speed of cash inflows.

Salarius Pharma (SLRX): Company Revenue from 07/04/2022 to 01/08/2026

Analytical breakdowns for Salarius Pharmaceuticals

- market price and analyst price targets:
Summary company analysis:Salarius Pharmaceuticals
Core merchandise of Salarius Pharmaceuticals Inc

Revenue dynamics reflect the intensity of market demand and the business's ability to generate cash flow, serving as the basis for determining the asset's fundamental value. For Salarius Pharmaceuticals (SLRX), the company's commercial sales volume remains zero due to the pre-commercial status of its developments, which turns this indicator into a marker of the absence of operating leverage and confirms a linear dependence of costs on R&D investments.

Competing companies

Company Revenue ONC|Revenue and Sales Volume HALO|RVMD (Revolution Medicines, Inc.) - Company Sales Revenue|Company Revenue Ascentage Pharma Corp AAPG|Company Total Sales Volume CG Oncology, Inc.|URGN - Company Revenue|Bicara Therapeutics Inc. (BCAX) - Company Sales|Personalis Inc (PSNL) - Company Revenue|ERAS - Company Gross Revenue|DCTH (Delcath Systems Inc) - Revenue and Sales Volume|Company Revenue YMAB|Revenue and Sales Volume AURA|Company Revenue CADL (Candel)|Accuray, Inc. - Company Sales|SELLAS Life Sciences Group Inc. - Company Revenue|ACTU: Company Sales|Company Total Revenue Citius Oncology Inc|HURA: Revenue and Sales Volume|TARA: Company Total Sales|FATE (fatetherapeutics.com) - Revenue and Sales Volume|Company Sales Aadi Bioscience Inc (WHWK)|Revenue and Sales Volume TCRX|CSBR - Company Total Revenue|Revenue and Sales Volume XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Company Total Revenue|OSTX: Company Sales|Company Sales Revenue RADX (Radiopharm Theranostics)|Artiva (ARTV) - Company Revenue|ANL: Company Total Sales|VERU (Veru Corporation) - Revenue and Sales Volume|Company Total Revenue Tempest Therapeutics, Inc. TPST|Revenue and Sales Volume XLO|Renovaro - Company Sales Volume|Company Revenue Mural Bio MURA|KAPA: Company Sales Volume|OnKure Therapeutics - Revenue and Sales Volume|Company Gross Revenue w2.cytomed.sg GDTC|CRIS: Revenue and Sales Volume|Company Sales Apollomics Inc.|THAR (Tharimmune Corporation) - Revenue and Sales Volume|Revenue and Sales Volume Advanced Biomed Inc|Revenue and Sales Volume GNPX|Company Sales Calidi Biotherapeutics Inc. CLDI|Company Revenue Sunshine Biopharma Inc. SBFM|Company Gross Revenue Xenetic Biosciences (XBIO)|purple-biotech.com - Revenue and Sales Volume|Company Total Revenue American Oncology Network, Inc.|BGNE: Revenue and Sales Volume|Company Sales checkpointtx.com|Company Revenue Elevation Oncology, Inc.|iCAD, Inc. (ICAD) - Company Gross Revenue|Company Revenue Ikena (IKNA)|NTBL - Company Total Revenue|Company Revenue viracta.com VIRX|morphosys.com (MOR) - Company Total Revenue|NAYA Biosciences Inc - Revenue and Sales Volume|AAPGV: Company Revenue